PRKDC and cancer: For example, Stronach et al. demonstrated that AKT relocates to the nucleus of cisplatin-resistant cancer cells where it is phosphorylated specifically on S473 by DNA-PK, and this activation inhibits cisplatin-mediated apoptosis.